Mural Oncology Plc (MURA)

Jan 27, 2025

Jones Trading sets $16 target on Mural Oncology stock By Investing.com - Investing.com Nigeria

Jan 27, 2025

Jan 27, 2025

This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Jan 27, 2025

Jan 27, 2025

Jones Trading Initiates Coverage of Mural Oncology (MURA) with Buy Recommendation - MSN

Jan 27, 2025

Jan 12, 2025

Geode Capital Management LLC Purchases 4,731 Shares of Mural Oncology plc (NASDAQ:MURA) - Defense World

Jan 12, 2025

Jan 10, 2025

Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts - The Manila Times

Jan 10, 2025

Jan 09, 2025

Mural Oncology Expands Pipeline with Two Novel Cancer Therapies, Advances Key Clinical Trials - StockTitan

Jan 09, 2025

Dec 26, 2024

Mural Oncology's chief legal officer sells $8,354 in shares By Investing.com - Investing.com Australia

Dec 26, 2024

Dec 26, 2024

Mural Oncology's chief legal officer sells $8,354 in shares - Investing.com India

Dec 26, 2024

Dec 25, 2024

Fmr LLC Grows Stake in Mural Oncology plc (NASDAQ:MURA) - Defense World

Dec 25, 2024

Dec 20, 2024

2025 will be a big year for Mural Oncology's drugs in development - The Business Journals

Dec 20, 2024

Dec 19, 2024

BNP Paribas Financial Markets Lowers Stake in Mural Oncology plc (NASDAQ:MURA) - Defense World

Dec 19, 2024

Dec 19, 2024

Mural Oncology stock hits 52-week low at $2.87 By Investing.com - Investing.com UK

Dec 19, 2024

Dec 18, 2024

Mural Oncology CEO Caroline Loew sells shares worth $9,394 - Investing.com

Dec 18, 2024

Dec 18, 2024

Mural Oncology CEO Caroline Loew sells shares worth $9,394 By Investing.com - Investing.com UK

Dec 18, 2024

Dec 09, 2024

Mural Oncology plc (NASDAQ:MURA) Shares Sold by Verition Fund Management LLC - MarketBeat

Dec 09, 2024

Dec 07, 2024

Mural Oncology GAAP EPS of -$1.84; reaffirms financial guidance - MSN

Dec 07, 2024

Dec 04, 2024

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 04, 2024

Dec 03, 2024

Mural Oncology Awards Key Talent with Stock Options and RSU Inducement Grants - StockTitan

Dec 03, 2024

Dec 02, 2024

Analysts Give Strong Buy Rating To This Undervalued Medical Stock (MURA) With Up To 350% Of Share Price Upside - Benzinga

Dec 02, 2024

Nov 25, 2024

Alkermes to Participate in Upcoming Investor Conferences - Quantisnow

Nov 25, 2024

Nov 24, 2024

Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Nov 24, 2024

Nov 22, 2024

Rodman & Renshaw Initiates Coverage of Mural Oncology (MURA) with Buy Recommendation - MSN

Nov 22, 2024

Nov 21, 2024

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer - The Manila Times

Nov 21, 2024

Nov 20, 2024

Mural Oncology's Cancer Drug Shows 33% Response Rate in Melanoma Trial Data | MURA Stock News - StockTitan

Nov 20, 2024

Nov 18, 2024

HC Wainwright Raises Earnings Estimates for Mural Oncology - Defense World

Nov 18, 2024

Nov 18, 2024

HC Wainwright Predicts Stronger Earnings for Mural Oncology - MarketBeat

Nov 18, 2024

Nov 16, 2024

MURAMural Oncology plc Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nov 16, 2024

Nov 15, 2024

Armistice Capital, LLC Increases Stake in Mural Oncology PLC - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress - The Manila Times

Nov 13, 2024

Nov 13, 2024

Mural Oncology plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Mural Oncology Reports 38% Lower Net Loss, Hits Trial Enrollment Milestones in Q3 | MURA Stock News - StockTitan

Nov 13, 2024

Nov 11, 2024

HC Wainwright Reaffirms "Buy" Rating for Mural Oncology (NASDAQ:MURA) - MarketBeat

Nov 11, 2024

Nov 11, 2024

Mural Oncology to Participate in Two Upcoming Investor Conferences - The Manila Times

Nov 11, 2024

Nov 11, 2024

Mural Oncology (MURA) to Present at Major Healthcare Investor Conferences | MURA Stock News - StockTitan

Nov 11, 2024

Nov 08, 2024

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times

Nov 08, 2024

Nov 07, 2024

Mural Oncology Reports Promising Cancer Trial Data, Plans Key 2025 Readouts | MURA Stock News - StockTitan

Nov 07, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Mural Oncology PLC H - GuruFocus.com

Nov 05, 2024

Nov 01, 2024

Mural Oncology CFO Adam Cutler sells $25,305 in company stock By Investing.com - Investing.com Canada

Nov 01, 2024

Nov 01, 2024

Mural Oncology plc (NASDAQ:MURA) CFO Adam D. Cutler Sells 7,421 Shares - MarketBeat

Nov 01, 2024

Nov 01, 2024

Mural Oncology CFO Adam Cutler sells $25,305 in company stock - Investing.com

Nov 01, 2024

Oct 28, 2024

Short Interest in Mural Oncology plc (NASDAQ:MURA) Decreases By 15.7% - MarketBeat

Oct 28, 2024

Oct 21, 2024

HC Wainwright Comments on Mural Oncology Q3 Earnings - MarketBeat

Oct 21, 2024

Oct 17, 2024

Mural Oncology (NASDAQ:MURA) Coverage Initiated at HC Wainwright - MarketBeat

Oct 17, 2024

Oct 17, 2024

H.C. Wainwright initiates coverage on Mural Oncology stock with Buy rating - Investing.com UK

Oct 17, 2024

Oct 10, 2024

167,644 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Squarepoint Ops LLC - MarketBeat

Oct 10, 2024